<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03423953</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CR.GE2.13</org_study_id>
    <nct_id>NCT03423953</nct_id>
  </id_info>
  <brief_title>Comprehensive Nano - PMCF Study</brief_title>
  <official_title>Comprehensive Nano Post Market Data Collection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      This data collection project is intended to provide clinical outcomes data to engineering,
      marketing as well as fulfill the post market surveillance requirements of various regulatory
      authorities. The study will be a prospective and one-arm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ComprehensiveÂ® Shoulder System with Nano humeral component is a humeral prosthesis system
      intended for use in total or hemi shoulder arthroplasty surgery. Total shoulder arthroplasty
      consists of replacement of the humeral head and glenoid. Hemi-arthroplasty consists of
      replacement of only the humeral head.

      This project is a prospective study including one-hundred and fifty (150) anatomic and hemi
      cases and 44 reverse shoulders collected from up to ten (10) sites. All potential study
      subjects will be required to participate in the Informed Consent process.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2013</start_date>
  <completion_date type="Anticipated">July 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survivorship</measure>
    <time_frame>10 years</time_frame>
    <description>Kaplan Meier method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ASES Score (American Shoulder and Elbow Surgeons)</measure>
    <time_frame>10 years</time_frame>
    <description>Improvement in this score from preop to 10 year follow-up. This score includes 2 scales: 1 scale for pain, from 0 to 10 where 0 stands for &quot;no pain at all&quot; and 10 for &quot;pain as bad as it can be&quot;. The second scale is for the stability of the shoulder, from 0 to 10 (0 stands for &quot;very stable&quot; and 10 for &quot;very unstable&quot;).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SANE Score (Single Assessment Numeric Evaluation)</measure>
    <time_frame>10 years</time_frame>
    <description>Improvement in this score from preop to 10 year follow-up. This is a simple, single-question, patient-based shoulder function assessment tool: &quot;How would you rate your shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constant-Murley Score</measure>
    <time_frame>10 years</time_frame>
    <description>Improvement in this score from preop to 10 year follow-up. This is a 100-point score. Higher scores indicate a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>X-rays evaluated for radiolucencies, osteolysis, migration and subsidence</measure>
    <time_frame>10 years</time_frame>
    <description>Standard evaluation performed on both humeral and glenoid components</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">194</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Avascular Necrosis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Revision</condition>
  <condition>Correction of Functional Deformity</condition>
  <arm_group>
    <arm_group_label>Anatomic</arm_group_label>
    <description>Patients receiving the Anatomic or Hemi verison of the Comprehensive Nano.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reverse</arm_group_label>
    <description>Patients who have received the Reverse version of the Comprehensive Nano.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comprehensive Nano</intervention_name>
    <description>Patients requiring the Comprehensive Nano shoulder system.</description>
    <arm_group_label>Anatomic</arm_group_label>
    <arm_group_label>Reverse</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in need of an uncemented shoulder arthroplasty and who meet all of the inclusion
        and none of the exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-inflammatory degenerative joint disease including osteoarthritis and avascular
             necrosis.

          -  Rheumatoid arthritis

          -  Revision where other devices or treatments have failed

          -  Correction of functional deformity.

          -  Difficult clinical management problems where other methods of treatment may not be
             suitable or may be inadequate

          -  Difficult clinical management problems where other methods of treatment may not be
             suitable or may be inadequate

        Exclusion Criteria:

          -  Infection

          -  Sepsis

          -  osteomyelitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Paola Vivoda</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emilie Rohmer</last_name>
    <email>emilie.rohmer@zimmerbiomet.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Privatklinik Leech</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Michael KRIFTER, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 3N6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Bicknell, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospial Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <state>Languedoc-Roussillon</state>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Chammas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Centre</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Liverpool</name>
      <address>
        <city>Liverpool</city>
        <state>Merseyside</state>
        <zip>L69 3BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frostick Simon, Prof.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Canada</country>
    <country>France</country>
    <country>Korea, Republic of</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2018</study_first_submitted>
  <study_first_submitted_qc>February 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2018</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoarthritis</keyword>
  <keyword>avascular necrosis</keyword>
  <keyword>rheumatoid arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Osteonecrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

